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1Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, New YorkABSTRACT Agonists turn on receptors because their target sites have a higher affinity in the active versus resting conforma-
tion of the protein. We used single-channel electrophysiology to measure the lower-affinity (LA) and higher-affinity (HA) equilib-
rium dissociation constants for acetylcholine in adult-type muscle mouse nicotinic receptors (AChRs) having mutations of
agonist binding site amino acids. For a series of agonists and for all mutations of aY93, aG147, aW149, aY190, aY198,
εW55, and dW57, the change in LA binding energy was approximately half that in HA binding energy. The results were analyzed
as a linear free energy relationship between LA and HA agonist binding, the slope of which (k) gives the fraction of the overall
binding chemical potential where the LA complex is established. The linear correlation between LA and HA binding energies
suggests that the overall binding process is by an integrated mechanism (catch-and-hold). For the agonist and the above
mutations, k ~ 0.5, but side-chain substitutions of two residues had a slope that was significantly higher (0.90; aG153) or lower
(0.25; εP121). The results suggest that backbone rearrangements in loop B, loop C, and the non-a surface participate in both
LA binding and the LA4 HA affinity switch. It appears that all of the intermediate steps in AChR activation comprise a single,
energetically coupled process.INTRODUCTIONThe neuromuscular adult-type muscle mouse nicotinic re-
ceptor (AChR) is a five-subunit, ligand-gated ion channel
that undergoes a global allosteric transition that shuts and
opens a transmembrane pore (1–4). The equilibrium constant
of this transition increases dramatically when neurotrans-
mitter molecules occupy two sites located in the extracellular
domain of the protein. When both sites are empty (filled only
with water), the equilibrium constant is small (E0 ¼ ~7.4 
107) and there is almost no resting current, but when acetyl-
choline (ACh) is present at both sites the equilibrium con-
stant is large (E2
ACh ¼ 25) and the probability of being in
an ion-conducting conformation (PO) is transiently ~1. The
increase in the equilibrium constant with versus without
ACh is generated by a decrease in the equilibrium dissocia-
tion constant (increase in affinity) at each of two agonist sites
that happen to be functionally equivalent for ACh in wild-
type (WT) adult mouse muscle AChRs.
Agonists diffuse from the extracellular space to reach
their target sites. In many proteins, rapid structural fluctua-
tions at binding sites probably influence the apparent rate
constants for ligand association and dissociation (5,6).
Here we explore brief, intermediate states in agonist binding
to AChRs arising from such rapid, local conformational
changes by measuring correlations between the energies
for the formation of lower-affinity (LA) and higher-affinity
(HA) complexes.Submitted December 12, 2013, and accepted for publication April 23, 2014.
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0006-3495/14/07/0088/12 $2.00A cyclic model of receptor activation provides the
foundation for estimating the difference in binding energy
(Fig. 1 a) (7,8). We use the symbols C(losed) 4 O(pen)
to represent the stable end-states of the global isomerization.
The ratio of equilibrium dissociation constants, C versus O
(LA versus HA), is called the coupling constant, which can
also be calculated from the cycle from the diliganded versus
unliganded transition equilibrium constants: l ¼ O(E2/E0).
For ACh and mouse adult WT AChRs, l z 5900 at each
agonist site (9,10). This ratio is smaller for partial agonists;
for instance, anabasine (Ana; ~5500), carbamylcholine
(CCh; ~3000), tetramethylammonium (TMA; ~2000), nico-
tine (Nic; ~1000), choline (Cho; ~250), and betaine (~5)
(11,12). The logarithms of these values are proportional to
the net energy from the affinity change for each agonist
molecule that contributes to increasing PO.
The components of l, which are the LA equilibrium
dissociation constant Kd and the HA equilibrium dissocia-
tion constant Jd, can also be estimated from single channel
currents. In WT AChRs, activation by agonists from C
occurs mainly by the clockwise path around the cycle, so
most events in the current record arise from LA binding
and diliganded gating. Consequently, Kd can be estimated
by fitting the current interval durations by a linear activation
scheme using a range of agonist concentrations (see Mate-
rials and Methods). In WT adult mouse AChRs, Kd
ACh z
166 mM (13,14). Jd can be calculated by using the constraint
of the cycle (l ¼ Kd/Jd) or from direct measurements of
single-channel currents. Background mutations can increase
the level of constitutive activity to an extent that thehttp://dx.doi.org/10.1016/j.bpj.2014.04.057
FIGURE 1 Function and structure. (a) Cyclic model for activation of
AChRs having two functionally equivalent agonist sites. LA is lower affinity
and HA is higher affinity. C and O are the global closed- and open-channel
structural ensembles (LA and HA) and A is the agonist. The bold pathway is
Eq. 1. DG is the free energy difference between end states. (b) The ligand
binding site of the Lymnea acetylcholine binding protein (AChBP;
PDB:1UV6 (18)), which is a model for the AChR agonist site. The bound
ligand is carbamylcholine (CCh) and the residue numbers are for the mouse
a (top) or ε (bottom) subunits. εP121 is a serine in AChBP so only the aC
atom is shown. Residues are colored according to their k-values (see Fig. 5):
(purple) 0.90; (green) ~0.5; (red) 0.25.
AChR Activation Mechanism 89counterclockwise path around the cycle dominates at low
agonist concentrations. As with Kd estimation, Jd can be
estimated directly by fitting interval durations by a linear
activation scheme using a range of agonist concentrations
(15,16). In a different approach, the HA agonist dissociation
rate constant can be estimated by using mutations that in-
crease E2 substantially and, hence, force deactivation to
occur by agonist dissociation from O rather than from C
(17). These methods produce estimates that are in reason-
able agreement, with that given by the cycle calculation asJd
ACh z 28 nM. Our goals were to estimate Kd and Jd in
AChRs having binding site mutations and then measure cor-
relations between the LA and HA binding energies.
The adult neuromuscular AChR agonist sites are located
at the aε and ad subunit interfaces (Fig. 1 b; and see
Celie et al. (18)). The a-subunit side of each pocket has
three loops (A, B, and C) which hold four aromatic amino
acids and two glycines that are important in setting the
resting, LA dissociation constant for ACh. The non-a side
has a conserved proline and conserved tryptophan that
also influence activation by agonists. We have examined
the effects of mutations of these eight residues on LA and
HA agonist binding.
The results are presented in sections. First, we provide a
framework for understanding LA and HA binding of ago-
nists to AChRs. Then, we present estimates for the LA
and HA binding energies of agonists to receptors having a
mutation at one of the above amino acids. Finally, we
analyze the correlation between the LA and HA binding
free energies in the form of a linear free energy relationship.
The results are discussed with regard to possible structural
correlates of the energies, and to intermediate states in
AChR activation.MATERIALS AND METHODS
Mutagenesis and expression
Human embryonic kidney (HEK293) cells were maintained at 37C (95%
air and 5% CO2) in Dulbecco’s minimum essential medium supplemented
with 10% (vol/vol) fetal bovine serum plus 1% (vol/vol) penicillin-strepto-
mycin (pH 7.4). Mutations were created using a Quik-Change site-directed
mutagenesis kit (Stratagene, LA, Jolla, CA) and confirmed by dideoxy
sequencing of the cDNA samples. HEK cells were transiently transfected
with a mixture of cDNAs (abdε, 2:1:1:1 ratio, ~3.5 g/35-mm dish) encoding
wild-type (WT) or mutant mouse subunits, by calcium phosphate precipita-
tion. cDNA encoding GFP (0.1g/L/dish) was added as a marker. The cells
were washed after ~16 h and electrophysiological recording commenced
within 24–48 h.Electrophysiology
Single-channel currents were recorded in the cell-attached patch configura-
tion at 23C. The bath solution was 142 mM KCl, 5.4 mM NaCl, 1.8 mM
CaCl2, 1.7 mM MgCl2, and 10 mM HEPES/KOH (pH 7.4). The patch
pipettes were filled with agonist diluted with Dulbecco’s phosphate-
buffered saline containing 137 mM NaCl, 0.9 mM CaCl2, 2.7 mM KCl,
1.5 mM KH2PO4, 0.5 mM MgCl2, and 8.1 mM Na2HPO4 (pH 7.3,
NaOH). When agonist was present (only in the pipette), the electrode
potential was held at100 mV, which corresponds to a membrane potential
of ~þ100 mV. Patch pipettes were pulled from borosilicate capillaries to a
resistance of ~10 MU and coated with Sylgard (Dow Corning, Midland,
MI). Single-channel currents were recorded using a PC-505B amplifier
(Warner Instruments, Hamden, CT) with external low-pass filtering
(LPF-8, Warner Instruments) at 20 kHz and digitized at a sampling fre-
quency of 50 kHz using an SCB-68 data acquisition board (National Instru-
ments, Austin, TX).
The agonist was ACh for almost all constructs. Mutations of most of the
binding site residues in question have a small effect on E0 but reduce l sub-
stantially, so that the apparent E2
ACh was in a range that could be readilyBiophysical Journal 107(1) 88–99
90 Purohit et al.measured. However, we could not study aG153 using ACh because all
mutations of this residue increase E0 substantially and hardly affect l, so
that E2
ACh (specifically, the opening rate constant) was too large to be
measured accurately. We could not use a protein engineering approach to
allow the aG153 mutant measurements because background mutations
away from the binding site that decrease E0, specifically by decreasing
the opening rate constant and without affecting agonist binding, were not
available. We therefore studied aG153 using two partial (lower-l) agonists,
TMA and Nic.Rate constant estimation
The single-channel currents were acquired and analyzed using the software
QUB (www.qub.buffalo.edu). Openings were clustered, with intervals
within clusters reflecting mostly binding/gating and those between clusters
reflecting sojourns in states associated with desensitization. The intracluster
currents were idealized into noise-free intervals (after digitally low-pass
filtering, 10–15 kHz) by using the segmental k-means algorithm (19)
with a two-state, (C 4 O) model. Rate constants were estimated from
the idealized interval durations by using a maximum log-likelihood algo-
rithm (20) after imposing a dead-time and correction of 50 ms. Voltage
and mutational background perturbations were used to place the interval
durations into a range most-suitable for patch-clamp measurement (~0.1–
10 ms) (11). These perturbations only change the intrinsic gating equilib-
rium constant (DG0) and had no effect on diffusion or binding. The results
shown in Table 1 have been corrected for the backgrounds, to pertain to the
WT background,100 mV. The standard deviations of the equilibrium con-
stants are all%15% of the means.Kd estimation
Kd was estimated by using two methods. The first method was to fit interval
durations from single-channel current clusters using a 2A þ C 4 A þ
AC4A2C4A2Omodel (the clockwise, outer cycle of Fig. 1 a). The firstTABLE 1 Equilibrium constants and energies
Construct E2 E0 Kd Jd D
WT 25.4 7.4E07 0.166 2.8E05 
aY93W 0.54 1.8E07 2.01 1.2E03 
H 1.83 1.5E06 3.20 2.9E03 
A 0.58 7.0E07 1.21 1.3E03 
F 0.67 3.3E06 2.59 5.8E03 
S 0.16 8.3E07 6.24 1.4E02 
aW149Y 1.425 2.1E06 2.41 3.0E03 
F 1.127 2.4E06 12.82 1.9E02 
A 0.073 5.8E06 28.83 2.6E01 
aY190F 0.021 4.3E07 3.60 1.6E02 
W 0.014 1.0E06 6.46 5.6E02 
A 5.3E05 6.7E07 16.52 1.9Eþ00
aY198F 12.46 6.5E07 0.23 5.3E05 
H 0.28 7.1E-07 5.70 9.1E03 
W 0.89 1.9E06 0.61 8.8E04 
S 0.11 9.9E07 3.90 1.2E02 
T 0.05 8.7E07 9.20 3.8E02 
L 0.03 8.1E07 4.10 2.1E02 
A 0.03 8.8E07 7.50 4.1E02 
εP121L 0.08 7.4E07 0.72 2.2E03 
Y 0.06 3.5E07 1.27 3.0E03 
G 0.013 1.9E08 1.00 1.2E03 
E0 and E2, gating equilibrium constants without and with ligands (ACh), were p
stants to C and O (in millimolar ); DGHA high-affinity binding energy, DGLA low
Energies are kcal/mol.
Biophysical Journal 107(1) 88–99and second steps are sequential agonist binding to the two binding sites.
Both association rate constants were scaled linearly with [ACh]. Because
in adult-type AChRs both sites are functionally equivalent for ACh, the first
association rate constant was constrained to be twice that of the second
(kon), and the second dissociation rate constant was constrained to be twice
that of the first (koff). Thus, the rate constant kon and koff pertain to single
binding sites. The intervals were fit globally, using interval durations for
patches exposed to multiple [ACh]. Care was taken to eliminate intervals
arising from sojourns in a short-lived desensitized state. Kd was calculated
from the fitted association and dissociation rate constants (¼ koff/kon). In the
second method for estimating Kd, a plot of cluster PO versus [ACh] was
fitted by the equation
PO ¼ ð½ACh=KdÞ2  E2

1þ 2  ½AChKd
þ ð½ACh=KdÞ2 þ ð½ACh=KdÞ2  E2

;
where E2 is the diliganded gating equilibrium constant (¼ f2/b2). For each
construct, the opening rate constant f was fixed to be that measured at2
140 mM ACh and the closing rate constant b2 was fixed to be the inverse
open time at 100 mM ACh. The kinetic modeling and steady-state, dose-
response methods gave equivalent results for Kd. The methods for analyzing
the single site mutations εP121 and εW55/dW57 are described in Gupta
et al. (21). Briefly, DGB and Kd from the unmutated site were assumed to
be the same as in the WT (for ACh, 5.1 kcal/mol and 166 mM).Cycle equations
We assumed that the mutations had equivalent effects at the two binding
sites. From Hess’s law, and with functionally equivalent transmitter binding
sites (Fig. 1 a), 2DGLA þ DG2 ¼ DG0 þ 2DGHA. Define DGB ¼ DGHA 
DGLA. Rearranging, DG2 ¼ DG0 þ 2DGB. For one site, DGLA þ DG1 ¼
DG0 þ DGHA, or DG1 ¼ DG0 þ DGB. Each equilibrium constant (Keq)
was usually calculated from a ratio of rate constants, and the correspond-
ing free energy (kcal/mol, 23C) was calculated as 0.59ln(Keq). ErrorsGHA DGLA DGB DDGHA DDGLA DDGB
6.18 1.06 5.12 — — —
3.99 0.41 4.40 2.19 1.47 0.72
3.45 0.69 4.13 2.73 1.75 0.99
3.91 0.11 4.02 2.27 1.17 1.10
3.04 0.56 3.60 3.14 1.62 1.52
2.51 1.08 3.59 3.67 2.14 1.53
3.44 0.52 3.95 2.74 1.58 1.17
2.34 1.51 3.85 3.84 2.57 1.27
0.80 1.98 2.78 5.38 3.04 2.34
2.44 0.76 3.20 3.74 1.82 1.92
1.70 1.10 2.81 4.48 2.16 2.31
0.36 1.65 1.29 6.54 2.71 3.83
5.81 0.86 4.95 0.37 0.20 0.17
2.78 1.03 3.80 3.40 2.09 1.32
4.15 0.29 3.86 2.03 0.77 1.26
2.62 0.80 3.43 3.56 1.86 1.69
1.92 1.31 3.23 4.26 2.37 1.89
2.27 0.83 3.10 3.91 1.89 2.02
1.88 1.19 3.07 4.30 2.25 2.05
1.91 0.19 1.72 4.27 0.87 3.40
1.86 0.14 2.00 4.32 1.20 3.12
2.81 0.00 2.81 3.37 1.06 2.31
ublished previously (11,21,27,28); Kd and Jd, equilibrium dissociation con-
-affinity binding energy; DGB, DGHA  DGLA. DDG values are mutant-WT.
AChR Activation Mechanism 91in the energy measurements propagate as the square root of the sum of
the squared errors. We estimate that each DGHA and DGLA estimate has
an error of ~0.3 kcal/mol (21). Later in Fig. 5, each point is the mean
ofR3 patches.RESULTS
Framework
To set the framework for interpreting the experimental re-
sults for AChRs, we first consider sequential schemes that
capture most of what happens in physiological activation.
The simplest linear scheme for activation by an agonist
(A) of a one-binding-site receptor is the bold pathway in
Fig. 1 a (22):
Aþ C4AC4AO: (1)
The first step is called ‘‘binding’’ (implicitly assumed to be
by diffusion only) and the second step is called ‘‘gating’’,
which is everything that happens within a global allosteric
transition that includes the LA4HA change at the agonist
site and the opening and closing of the pore.
Three results suggest that formation of an LA com-
plex requires both diffusion and a protein conformation
change (23):
1. There is a wide range of LA association rate constants for
agonists having similar structures,
2. The differences in Kd for structurally related agonists and
agonist-site mutants is set almost exclusively by the asso-
ciation rate constant, which is unexpected from a strictly-
diffusional process, and
3. For the combination aG153S and choline, the association
rate constant is strongly temperature-dependent, which is
again inconsistent with a diffusional process (24).
These results suggest that for an agonist to form a LA com-
plex it must cross a chemical barrier, and that LA binding to
the resting state is not by diffusion alone.
Because diffusion is certainly required, this interpreta-
tion requires that an intermediate state can be inserted
into the binding step of Eq. 1. This state represents the
condition of an agonist that has arrived at the target
site by diffusion, but without the structural fluctuation
at the binding site that allows the formation of the
LA complex. The LA 4 HA switch at the agonist site,
too, can be encoded as an intermediate state, in this
instance within the gating step of Eq. 1. These consider-
ations lead to
Aþ C4AC4AC04AC004AO: (2)
The main symbols, C and O, indicate the overall shape of
the protein and the superscripts indicate local subconforma-
tions of the agonist site. In Eq. 2, a resting agonist site can
exist in four different substates that are connected by three
processes:1. Diffusion of the ligand to form an encounter complex;
2. A conformational change to form the LA complex
(catch); and
3. Another conformational change to form the HA complex
(hold).
AC is the encounter complex, AC0 is the LA complex, and
AC00 is the HA complex. The AC and AC00 states are too brief
to be detected in our experiments and, hence, are part of the
transition-state ensembles of the binding and gating steps of
Eq. 1. In our experiments, binding and gating each appear as
a simple, two-state process. We assume that the opening of
the pore does not change the conformation of the agonist
site, so in Eq. 2 the agonist site in theO state is double-primed
(the same as in C00). The first step of Eq. 2 is diffusion and the
last step contains all nonagonist-site rearrangements within
the global isomerization, including pore-opening.
To help imagine what might be occurring structurally in
Eq. 2, Fig. 2 shows a speculative sketch of agonist-site con-
figurations in each state. ‘‘Catch’’ is represented as the rota-
tion of the left side of the binding pocket and ‘‘hold’’ as
the rotation of the right side, with each rearrangement
increasing the stability of the ligand. Equation 1 does not
distinguish diffusion and catch nor does it separate hold
and, for instance, pore-opening. Here we have inferred the
existence AC00 from a consideration of the LA versus HA
agonist site, but there may be direct experimental evidence
for this state from high-resolution kinetic analyses of gating
(see Discussion).
The diffusion, catch, and hold steps in Eq. 2 each have a
corresponding free energy change. For a series of structurally
related agonists and WT AChRs, the energy change of the
catch rearrangement is correlated with that of hold (23).
For this series, the difference in LA catch energy for different
ligands was, in all cases, about equal to that for LA4 HA
hold. This correlation implies that after diffusion, the two
affinity-changing rearrangements comprise a single, inte-
grated process (catch-and-hold) that involves two energeti-
cally related changes in agonist-site structure. As shown in
Fig. 2 (bottom), the experimentally observed equilibrium
association constant for LA binding is 1/Kd, which is set by
both agonist diffusion and the catch rearrangement, and the
hold step contributes to the equilibrium constant of the global
transition (with one agonist,E1). In AChRs, the correlation in
energies of the affinity-changing rearrangements is such that
knowledge of the agonist’s resting affinity is sufficient to pre-
dict accurately the gating equilibrium constant (efficacy),
and vice versa. A similar correlation between LA binding
and efficacy has been observed in a related ligand-gated
ion channel, the GABAA receptor (25).LA and HA energies in mutant AChRs
LA agonist binding and the allosteric transition are linked in
a thermodynamic cycle (Fig. 1 a). The apparent equilibriumBiophysical Journal 107(1) 88–99
FIGURE 2 Speculative sketch of a single agonist site (Eq. 2). (Top) Cartoon structures. (Arcs) Loops at the agonist site; (solid circle) agonist; (open
circles), side chains that stabilize the agonist; (horizontal line at bottom), the conductance of the pore. The left loop rotates in catch and the right in
hold. (Middle) Equation 2. A, agonist; C and O, alternative structures of the global transition; superscripts, subconfigurations of the agonist site (0 for catch
and 00 for catchþhold; the O state is 00). LA, low affinity; HA, high affinity. Only the first and last steps are by diffusion. Not shown, hold without catch and
ligand binding to C0 and C00. (Bottom) Experimental equilibrium constants that pertain to LA binding (1/Kd), gating with one bound agonist (E1), and HA
binding (1/Jd).
92 Purohit et al.association constant for LA binding (1/Kd) and the gating
equilibrium constant with two and without any bound
ACh molecules (E2 and E0) were estimated from single-
channel interval durations. The equilibrium association
constant for HA binding (1/Jd) was calculated from these
experimental estimates by using the cycle, assuming
detailed balance.
We used background mutations and depolarization to
facilitate the interval duration measurements and to elimi-
nate channel block by the agonist (11). Experiments show
that these perturbations affect only E0 and have no effect
on the binding process. The effects of the backgrounds
were known a priori and were independent of those of those
arising from the agonist site mutations, so the observed
equilibrium constants could be corrected to pertain to WT
AChRs (100 mV).
As an example, we detail this protein engineering method
for the mutation aY190F (Figs. 1 b and 3). To estimate
E0
aY190F, constitutive activity was increased over that of
the WT by using the background mutations (aD97Aþ
aY127FþaS269I), which together increase the unliganded
gating equilibrium constant by ~60,000-fold without having
any effect on agonist binding (10). Adding aY190F to this
background reduced the apparent unliganded gating equilib-
rium constant E0
obs by 1.7-fold. We know that, in adult
AChRs, E0
WT ¼ 7.4  107 (9,10,26), so we estimate
E0
aY190F ¼ 4.3  107. To estimate E2aY190F(ACh), two
different background perturbations were applied (εL269F
and depolarization to þ100 mV), which together increase
E0
WT by ~15-fold (11). We then used 140 mM ACh (a satu-
rating concentration) to measure the apparent diliganded
gating equilibrium constant E2
obs ¼ 0.31. E2 is proportional
to E0, so we divided the observed value for ACh by 15 to
estimate E2
aY190F(ACh) ¼ 0.021 (at 100 mV). From the
cycle l ¼ O(E2/E0), so we calculate that laY190F(ACh) ¼Biophysical Journal 107(1) 88–99221 in the mutant, which is ~26-fold smaller than in the
WT. The apparent LA binding rate constants were then esti-
mated by fitting a two-site, sequential activation scheme
(see Materials and Methods) by the closed and open interval
durations globally, over a range of [ACh] and using the
same background used to estimate E2
ACh. The results were
kon ¼ 2354 5 124 mM1 s1 and koff ¼ 8493 5 563 s1
(mean 5 SD), to give the estimate Kd
aY190F(ACh) ¼
3.6 mM (¼ koff/kon). From the cycle (l ¼ Kd/Jd), we calcu-
late that Jd
aY190F(ACh) ¼ 16 mM. Hence, we estimate that
the aY190F mutation reduced LA by ~21-fold and HA by
~551-fold.
The results for all mutations are given in Tables 1 and 2
(and see Purohit and Auerbach (27)). Mutations of the aro-
matic residues all increased Kd
ACh and decreased E2
ACh
relative to the WT, but had relatively small effects with
regard to E0.
The next step was to turn the Kd
ACh and Jd
ACh estimates
for each mutation into energies. The log of an equilibrium
constant is proportional to the free energy difference be-
tween the stable end-states (product minus reactant). The
salient free energies for the cycle’s reactions are (Fig. 1 a):
DGLAðAþ C4AC; ¼ þ0:59lnKdÞ;
DGHAðAþ O4AO; ¼ þ0:59lnJdÞ;
DG0ðC4O; ¼ 0:59lnE0; the allosteric constantÞ; and
DG2ðA2C4A2O; ¼ 0:59lnE2Þ
The log of l, the coupling constant, is proportional to the
difference in ACh binding energy, O versus C (DG ¼B
DGHA  DGLA).
DGB is the energy that generates the increase in PO
caused by agonists. Residues and chemical groups that
contribute to DGB in WT AChRs have been identified by
mutational analyses (28). The change in DGB consequent
FIGURE 3 Using protein engineering methods to estimate equilibrium
constants. (a) The un- and diliganded gating equilibrium constants E0
and E2 were estimated from the ratio of open/shut time constants
(main component). (Top) Unliganded. Background mutations (aD97A þ
aY127F þ aS269I; no effect on binding) increase spontaneous gating
(open is down; the flanks of the cluster are long-lived desensitized states).
Adding aY190F reduced E0
obs by 1.7-fold. E0
WT ¼ 7.4  107, so with a
WT background E0
aY190F ¼ 4.3  107. (Bottom) Diliganded (open is
up). Background perturbations (εL269F and depolarization to þ100 mV)
have no effect on binding and together increase E0 ~ 15-fold relative to
the WT. E2
obs ¼ 0.31, so with a WT background (100 mV) we estimate
E2
aY190F(ACh) ¼ 0.021. (b) LA association and dissociation rate constants
estimated by fitting a sequential model to shut and open interval
durations globally, over a range of [ACh]. The apparent equilibrium con-
stants are Kd
aY190F ¼ 3.6 mM and JdaY190F ¼ 16 mM. Results for other
mutations are in Table 1.
AChR Activation Mechanism 93to, for example, a Y/ F substitution estimates the ener-
getic contribution of the tyrosine’s -OH group, and the
change from a F/A substitution gives that for the benzene
ring. Although we did not probe the underlying chemical
forces behind the DGB energy changes, it is likely that theformer can be attributed to the loss of an H-bond and the
latter to the loss of a cation-p interaction (29). We extended
this approach to probe the structural entities that determine
the separate components of DGB, namely DGHA and DGLA.
The energy changes from F and A substitutions of the a-sub-
unit aromatics are discussed below, and those for other
mutations are given in Tables 1 and 2.
aY190 is an important binding site residue that partici-
pates in setting both resting LA binding and E2
ACh. From
the logarithms of the fold-changes in l, Kd, and Jd given
above, we calculate that removal of the -OH group in
aY190F makes the net binding energy less favorable by
DDGB
ACh ¼ þ1.9 kcal/mol, with the unfavorable change
in LA binding energy (DDGLA
ACh ¼ þ1.8 kcal/mol) being
less than for HA binding (DDGHA
ACh ¼ þ3.8 kcal/mol).
The -OH group of aY190 makes approximately twice the
energy contribution to ACh affinity when the site is in its
O versus its C conformation.
The corresponding energy values for the Y/F substitu-
tion of aY198 are given in Table 1. Energetically, the -OH of
aY198 is almost without consequence to both LA and HA
binding.
To estimate the effect of just the aromatic group, we
measured LA and HA binding energy changes consequent
to F/A substitutions. Previous results suggested that the
A substitution mainly removes the contribution of the ben-
zene ring and does not add or subtract significant energy
by making new interactions (28).
ForaY190, the energychangeswith anF/Areplacement
wereDDGLA¼þ0.9 kcal/mol andDDGHA¼þ2.8 kcal/mol,
with the contribution of the removal of the benzene ring to net
binding beingDDGB¼þ1.9 kcal/mol. Although the absolute
effect on LA binding from -OH removal (þ1.8 kcal/mol) was
approximately twice as great as for ring removal (þ0.9 kcal/
mol), the net contribution toDGBwas approximately the same
for both moieties.
At aY198, benzene ring deletion had an even more
substantial effect on both LA and HA binding, with
DDGLA ¼ þ2.3 kcal/mol and DDGHA ¼ þ4.4 kcal/mol.
However, the net effect on DGB (þ2.0 kcal/mol) was
approximately the same after removal of the aromatic
groups at both aY190 and aY198.
aW149 is a well-studied binding site residue that plays an
important role in AChR activation. The effects of the
aW149A mutation on ACh binding are given in Table 1.
Replacement of the indole ring with –H (W/A) results
in large binding energy losses, with DDGLA ¼ þ3.0 and
DDGHA ¼ þ5.4 kcal/mol. The reduction in favorable
DDGB energy was slightly larger for the deletion of the
aW149 indole (þ2.3 kcal/mol) than for the benzene rings
of aY190 and aY198 (~þ1.9 kcal/mol).
We also measured LA and HA binding energies in aro-
matic mutants of aW149. The energy loss was greater for
the F versus the Y substitution, with regard to both LA
and HA binding. Neither aromatic was a good substituteBiophysical Journal 107(1) 88–99
TABLE 2 Equilibrium constants and energies (published previously)
Construct E2 E0 Kd Jd DGHA DGLA DGB DDGHA DDGLA DDGB
WTACh 25.4 7.4E07 0.166 2.8E05 6.18 1.06 5.12 0.00 0.00 0.00
Ana 21 7.4E07 0.234 4.4E05 5.92 0.86 5.06 0.27 0.20 0.07
CCh 5.3 7.4E07 0.400 1.1Eþ03 5.20 0.54 4.66 0.99 0.52 0.47
NorNic 4.95 7.4E07 0.021 8.0E06 6.93 2.29 4.64 0.74 1.23 0.49
TMA 2.5 7.4E07 0.815 4.4E04 4.56 0.12 4.43 1.63 0.94 0.70
Nic 0.87 7.4E07 1.000 9.2E04 4.12 0.00 4.12 2.07 1.06 1.01
DMT 0.6 7.4E07 1.600 1.4Eþ03 3.74 0.28 4.01 2.45 1.34 1.12
DMP 0.4 7.4E07 2.091 2.8E03 3.46 0.44 3.89 2.73 1.50 1.24
Cho 0.05 7.4E07 4.200 1.6E02 2.43 0.85 3.28 3.76 1.91 1.85
aG147S 0.008 1.0E07 3.600 1.3E02 2.56 0.76 3.32 3.63 1.82 1.81
A 0.21 6.7E08 9.933 5.6E03 3.06 1.35 4.41 3.13 2.41 0.72
εW55A 1.9 9.6E07 3.578 2.5E03 3.52 0.75 4.28 2.67 1.81 0.85
E 4.4 3.0E06 1.632 1.3E03 3.90 0.29 4.19 2.29 1.35 0.94
F 4.5 3.7E07 0.611 1.8E04 5.10 0.29 4.81 1.09 0.77 0.32
Y 2.6 2.2E07 0.283 8.3E05 5.55 0.75 4.80 0.64 0.31 0.33
dW57A 17.2 7.4E08 4.462 2.9E04 4.80 0.88 5.68 1.39 1.94 0.55
F 7 7.4E08 0.227 2.3E05 6.29 0.88 5.42 0.10 0.18 0.29
H 8 5.9E07 0.309 8.4E05 5.54 -0.69 4.84 0.65 0.37 0.29
L 7 7.4E07 1.775 5.8E04 4.40 0.34 4.74 1.79 1.40 0.39
R 1.7 1.5E07 0.741 2.2E04 4.97 0.18 4.80 1.22 0.88 0.33
V 2.9 2.2E07 0.636 1.8E04 5.10 0.27 4.83 1.09 0.79 0.30
Y 16.3 3.0E07 1.506 2.0E04 5.02 0.24 5.26 1.17 1.30 0.13
aG153SCho 0.63 2.0E05 0.37 2.1E03 3.64 0.59 3.05 1.20 1.44 0.24
A 1.18 4.4E05 0.29 1.8E03 3.74 0.74 3.01 1.30 1.59 0.28
P 1.1 5.1E05 0.15 1.0E03 4.05 1.10 2.95 1.61 1.95 0.34
K 3 1.5E04 0.26 1.8E03 3.73 0.80 2.93 1.29 1.65 0.36
aG153SDMP 6.14 2.0E05 0.18 3.3E04 4.74 1.01 3.73 1.28 1.45 0.17
A 12.2 4.4E05 0.19 3.7E04 4.66 0.97 3.69 1.20 1.41 0.21
P 13.8 5.1E05 0.20 3.9E04 4.63 0.94 3.69 1.17 1.38 0.21
K 20.6 1.5E04 0.23 6.1E04 4.37 0.87 3.49 0.91 1.31 0.41
All results publishedpreviously:WT/agonists (23),aG147 (32), εW55, anddW57 (33),aG153Cho andaG153SDMP (34).All the equilibriumdissociationconstants
are in millimolar and the energies are kcal/mol (see Table 1 for column definitions). Rate and equilibrium constants pertain to ACh unless indicated otherwise
94 Purohit et al.for W, because they caused a >1 kcal/mol loss of net bind-
ing energy.Linear free energy relationships
Fig. 4 shows diffusion, catch, and hold for one binding site
in the form of an energy landscape. Because we assume
that the mutations do not alter diffusion, this process and
catch have been combined into a single step (A þ C 4
AC). This aggregate equilibrium association constant is
1/Kd, and that for the AC 4 AO step is E1. Hence, the
net equilibrium constant for the overall reaction is E1/Kd.
A log-log plot of 1/Kd versus E1/Kd for an agonist series
comprises a linear free energy relationship (LFER), the
slope of which (k) gives the energy (relative to C) of AC
as a fraction of that for AO. Kappa reflects the extent of
transition toward the HA state at the point when the LA
state has been established. For the agonist series and WT
AChRs, this slope is 0.52 5 0.01 (mean 5 SD; Fig. 5,
upper-left panel). This indicates that approximately one-
half of the total energy change experienced by the ligand
in catch-and-hold occurs in catch (the formation of the
LA complex) and approximately one-half in hold (the
LA4 HA switch).Biophysical Journal 107(1) 88–99A simple analogy of this LFER is that for channel block,
where the voltage dependence of the block equilibrium con-
stant (d) gives the position of the block site as a fraction of
the electric field (30). In the our analysis, the slope k gives
the position of the formation of the LA complex as a fraction
of the overall binding chemical potential, with each muta-
tion/agonist tilting this field to a different extent. As with
voltage in channel block, we assume that this tilt is linear
over the reaction coordinate.
We used this LFER framework to quantify the effects of
mutations of agonist site residues. If mutations do not affect
diffusion, DDGLA is equal to the change in energy from the
catch conformational change. The change in the energy for
the overall binding process is DDGLA þ DDG1, which (by
the cycle) is equal to DDG0 þ DDGHA (Fig. 1 a). Unlike
agonists, mutations can change DG0, so to explore specif-
ically the binding chemical potential profile (the probability
of being in O also tilts the landscape) we needed to know
each mutation’s effect on constitutive gating so that this
term could be removed from the LFER. DDG0 values for
each mutation have been measured previously (27,31).
The slope of a plot of DDGLA versus DDGHA for each
mutational series (k) gives the energy change of the
residue in catch as a fraction (between 1 and 0) of that in
FIGURE 4 Catch-and-hold energy landscape. Energy landscape for
agonist binding. The linear correlation of the energies of catch (formation
of the LA complex) and catchþhold (the formation of the HA complex)
implies that perturbations (agonists or mutations) tilt the overall chemical
potential to different extents (dotted lines). We assume that the agonist-
site mutations do not alter agonist diffusion or the rest of the events after
hold within the global transition. The slope of the plot of DGLA versus
DGHA (k) gives the position in the overall process at which the LA complex
is established. Experimental plots for k are shown in Fig. 5. For each step,
the change in the barrier height is proportional to the change in the end-state
energy.
AChR Activation Mechanism 95catch-and-hold. Kappa analysis of a two-step reaction is
related to f-analysis of a one-step reaction, because each
probes the fractional energy of an intermediate state. In
f-analysis this state is a barrier and in k-analysis it is a
well, but the correlation in energies between two points in
a landscape does not demand any particular shape for the
profile at the measured positions.
The equilibrium constants and energies for the newly-
probed mutations are given in Table 1, and those that were
published previously are given in Table 2. Fig. 5 shows bind-
ing LFERs for the agonist and mutations of the a-subunit
aromatic amino acids aY93, aW149, aY190, and aY198.
The k-values for these residues were similar to each other
and similar to the agonist series (~0.5). Put simply, all ago-nists and all mutations of these aromatic amino acids pro-
duced a fold-change in LA binding energy (relative to
ACh and WT) that was approximately one-half that in HA
binding energy. This suggests that all of these side chains
and the agonist establish the LA complex at approximately
the same point in the overall binding potential profile,
approximately midway through catch-and-hold.
Fig. 5 also shows binding LFERs for five other residues
that are near the binding site. aG147, εW55, and dW57
had k-values similar to the agonist and the four a-subunit
aromatics. However, the LFER slope for aG153 was greater
(0.90) and that for εP121 was lower (0.25) than those for
other structural elements at the agonist site. The high
k-value for aG153 was the same regardless of whether
Nic or TMA was the agonist.DISCUSSION
Energy-structure relationships
An energy change is a manifestation of a change in structure
or dynamics. Experiments show that in AChRs, most of an
energy change caused by a mutation can usually be pin-
pointed to the site of the side-chain substitution (31). We
therefore associate most of the measured changes in LA
and HA binding energies to arising from an agonist-site
mutation with the location of the perturbed side chain.
Some indication of the importance an amino acid plays in
the catch-and-hold process can be obtained from the range
of DDGHA values (the overall tilt of the binding landscape)
for each mutational series. The largest ranges were for
aW149, aY190, and aG153 (~6 kcal/mol) and the smallest
for dW57 (~2.5 kcal/mol). The other positions tested had a
range of ~4 kcal/mol. Based on the DDGHA range, aW149
(in loop B), aY190 (in loop C), and aG153 (in loop B)
appear to be the main players in setting the affinity of the
adult AChR agonist sites (28,29,32–37). It appears that
structural (energy) changes in loops B and C make the
largest contributions to ACh binding. The substantial
DGHA range at εP121 (but not dP123) suggests that confor-
mational changes on the complementary side of the pocket
are also significant in catch-and-hold, and are of greater
consequence at aε versus ad.
One of the results that led to the inference that LA binding
requires a protein conformational change was that agonists
of similar size, structure, and charge have a wide range of
LA association rate constants. We assumed that the diffu-
sional component of the apparent association rate constant
was the same for all ligands, and that the differences reflect
those in the equilibrium constant of the catch conforma-
tional change. This assumption can be questioned because
orientation effects could, for instance, make the diffusion
of TMA into the pocket slower than for ACh. However,
the observation that k for many residues is the same as for
the agonist series supports the above assumption becauseBiophysical Journal 107(1) 88–99
FIGURE 5 LFERS for agonist binding to adult-
type AChRs. The locations of the amino acids are
shown in Fig. 1 b. The k-value (linear slope of
the DDGLAversus DDGHA plot) is shown at the bot-
tom of each panel. In the top-left panel each symbol
is a different agonist and in all other panels each
symbol is a different side chain of that position
(in all cases, mean of R3 patches; Table 1). The
WT value is plotted at the origin. A more-positive
energy corresponds to a lower affinity.
96 Purohit et al.it is unlikely that all substitutions of all residues would
change agonist diffusion in the same, quantitative manner.
The simplest interpretation is that that the formation
of the LA complex requires a protein conformational
change, the equilibrium constant of which is influenced by
both the agonist and side chains.
The amino acids are colored by k-value in Fig. 1 b. Most
of the residues are green (k-range, 0.43–0.60; mean ¼ 0.53,
n¼ 7). Within this group, k for the aW149 mutants (0.595
0.06) is slightly larger, and for the aY190 mutants
(0.43 5 0.06) is slightly lower, than for the agonist series
(0.525 0.01). Hence, aW149 may play a somewhat larger
role in LA catch and aY190 a somewhat larger role in
LA 4 HA hold. Analyses of more substitutions of these
two positions, and of k-values in constructs that have
additional agonist site mutations, may reveal whether the
difference in LFER slopes between these two residues is sig-Biophysical Journal 107(1) 88–99nificant. Given the high k of another loop B residue, aG153
(see below), we hypothesize that loop B plays a larger role
in LA binding and loop C in the LA4 HA switch.
The agonist and residues aY190, aW149, aY198, aY93,
aG147, εW55, and dW57 all had k-values ~0.5. All of these
structural elements change energy approximately midway
through the catch-and-hold set of conformational changes.
This tight clustering of k-values stands in contrast to the
large range of LFER slopes in the allosteric transition,
where f-values in different regions of the protein range
from 1 to 0 (31). One explanation for this difference is
that the agonist and aromatic residues at the agonist sites
are close to each other and, therefore, likely to be coupled
energetically. This effect would make the catch-and-hold
set of rearrangements a concerted, group event. In contrast,
the side chains that resettle in the global transition are sepa-
rated and have movements that are mostly energetically
FIGURE 6 Nomenclature of intermediate steps and states. (Top) Equa-
tion 1: a single intermediate state (AC) between unliganded-C and
liganded-O. Binding is by diffusion alone and is independent of the global
gating isomerization. (Middle) Two intermediate states (AC and AC0). The
superscript indicates a conformational change has occurred at the agonist
site. Site-gate communication (priming) occurs upon entry into AC0, which
is a nonconducting microstate within the global allosteric transition. (Bot-
tom) Multiple intermediate states, including an encounter complex (AC),
an LA complex (AC0), an HA complex, and several more gating microstates
((AC00)n). Superscripts indicate the configuration of the agonist site, the first
mark for catch and the second, hold (O is double-prime). Site-gate commu-
nication may occur in the catch rearrangement (LA binding).
AChR Activation Mechanism 97independent. Hence, each side-chain energy change can
occur at different points within the global isomerization.
Another possible explanation for the k ~ 0.5 consistency is
that the catch-and-hold conformational change is intrinsi-
cally more restricted than for the global isomerization,
regardless of such energy coupling.
Two residues have k-values different from the main
group. aG153 has a k-value of ~0.9, measured by using
two different agonists. This residue changes energy mainly
in the LA rearrangement. Mutations of εP121, on the non-a
side of the pocket, significantly increase (make less favor-
able) DGHA with a k-value of ~0.25. This residue appears
to undergo its energy (structure) change mainly in the
LA4 HA hold rearrangement. Neither of these side chains
makes direct contact with ACh, raising the possibility that
the k¼ 0.5 consistency of the other amino acids is enforced,
in part, by coupling interactions with the ligand.
It is notable that the distinct value for k in aG153 is the
same with different agonists, and that k-values are the
same for different mutations of each residue (the LFER
slopes are constant). This suggests that the catch-and-hold
energy relationship is essentially independent of the struc-
tural details of the ligand and side chains. Our interpreta-
tions is that both the LA catch conformational change and
that of the LA 4 HA hold affinity-switch are generated
by local rearrangements of the agonist-site backbones, in
loops B and C in the a-subunit and in the b-strands on the
non-a side of the binding pocket.
The catch-and-hold mechanism impacts our thinking
about agonist binding to C versus O. In low, resting PO con-
ditions, the experimental association rate constant requires
an AC / AC0 rearrangement, but in AChRs having a
high constitutive PO (because of background mutations)
the agonist site has already undergone this transition
(Fig. 2). A prediction is that agonist association to O (jon)
is by diffusion alone, and, because the catch rearrangement
is not required, faster than to C (kon). This prediction is
supported by experiments showing that the higher affinity
of O is caused exclusively by a slower agonist dissocia-
tion rate constant (17) and that jon
ACh is large, and larger
than kon
ACh (15,16).
These observations are not consistent with the idea that in
the LA4HA switch, a capping motion of the loop-C back-
bone (38) creates a steric barrier that prevents the escape of
the agonist (closing a lid). If this were the case, association
would be slower to O than to C. Rather, the evidence sug-
gests that whatever the rearrangements are between agonist
site substructures in Eq. 2, they allow for unimpeded diffu-
sion of the agonist into the pocket in the O00 condition. An
example of an alternative mechanism could be that in
catch-and-hold, loop-B and -C backbone fluctuations cause
aromatic groups (aW149 and aY190) to move into the
pocket center, to stabilize the ligand (decrease the off rate
constant) without hindering agonist access. Although resi-
dues in loop C (aY190 and aY198) are indeed importantfor establishing both the LA and HA complexes, the rate
constant estimates suggest that loop C capping does not
establish the high affinity of O by shutting off a diffusional,
in-out pathway.Intermediate states in activation
Equation 1 was extended into Eq. 2 to incorporate new dis-
coveries about the AChR activation process. Here we have
considered AC00 as an HA agonist site, but this state has
been detected previously as an intermediate state within
the allosteric transition (see below). In physiological activa-
tion, AC00 can be thought of as both the end of binding and
the start of gating, and, hence, blurs the classical distinction
between these two processes. It is encouraging that in-depth
analyses of binding and gating both support the existence of
this intermediate state.
Intermediate states in the gating step of Eq. 1 have been
recognized for some time. Approximately 20 years ago,
analyses of single-channel currents revealed a brief, shut
event between AC and AO (Eq. 1), which led to the middle
scheme in Fig. 6 (39). The supposition then was that subunit
pairs that house agonist sites (ad and aε) underwent
sequential (stepwise) conformational changes within the
global isomerization, with the intermediate state reflecting
an AChR having had only one such transition. Later,
f-analyses of gating (40) led to the suggestion that there
are approximately five intermediate states in the global
isomerization, with one (f ~ 1) reflecting a conformational
change at the agonist site that forms the HA complex (41).
Phi analysis allows a higher-resolution view of the energy
within the AChR allosteric transition than can be achieved
from direct measurements of interval durations but suffersBiophysical Journal 107(1) 88–99
98 Purohit et al.from the drawback that it does not distinguish whether the
intermediate states are barriers or wells, or are associated
with an open or shut pore.
Two more-recent proposals regarding an AC 4 AO
intermediate state are closely related. An approximately
microsecond closure in glycine receptors (flip) has been in-
terpreted as reflecting a sojourn in a gating intermediate
state (42). Because different agonists influence only the
entry step, flip (like hold) likely reflects a local, agonist-
site conformational change. Although the flip equilibrium
constants violate detailed balance, this could be explained
by the (testable) hypothesis that ion flow through the pore
causes a transfer of energy into the system (43). A related
idea is that of priming, in which an agonist site rearrange-
ment perturbs a structural pathway to facilitate pore-
opening (44). Priming, too, is modeled as entry into an a
nonconducting gating intermediate state, with the addi-
tional, important idea that this event serves to enhance
(prime) channel-opening by transferring energy over a spe-
cific set of structures that mechanically connect the binding
sites and the gate.
These ideas are similar in that that all they invoke a local,
agonist-site rearrangement that can be represented as an in-
termediate state within the global AC4 AO transition of
Eq. 1. However, there are some differences. Phi analyses
indicate several intermediate states in the allosteric transi-
tion and, because the patch clamp does not have the tempo-
ral resolution to distinguish these separately, flip may reflect
an aggregate sojourn in all of these. Whereas ‘‘hold’’ refers
specifically to one intermediate event—the f ~ 1 agonist site
rearrangement that undergirds the LA 4 HA switch—
‘‘flip’’ could reflect, in addition, any or all of the micro-
scopic structural changes within the transition that precede
pore-opening, such as a contraction and twist of the extra-
cellular domain, bending of the M2 helix, and unpacking
of the gate itself (45). The direct detection of an intermedi-
ate closure between AC and AO is significant because,
unlike f-analysis, it shows that at least one intermediate
gating state is an energy well that corresponds to a shut
conformation.
The priming hypothesis is specific: capping of the loop-C
backbone over the agonist site is the structural correlate of
an intermediate gating event that triggers allosteric commu-
nication (priming) by a mechanical linkage. To our knowl-
edge, the new results reported here support the idea of a
loop-C backbone motion in hold (although not a lid-
closure), but also suggest that loop B and the non-a surface,
too, participate in this agonist-site rearrangement. It is note-
worthy that AChRs undergo the unliganded C4 O transi-
tion (Eq. 2, with water replacing the agonist) nearly
normally even when loop C has been removed, that commu-
nication between the agonist binding site and the gate may
not involve the proposed structural pathway (16), and that
such energy transfer over distance may not be entirely by
a mechanical linkage (31). The priming proposal is a usefulBiophysical Journal 107(1) 88–99concept because it addresses the important issue of how
energy flows between the agonist sites and the gate, but
perhaps not by this specific, cuckoo-clock mechanism.
The existence of a catch conformational change offers the
possibility that communication between the agonist site and
the gate region in AChRs commences with LA binding of
the agonist rather than with the LA/ HA rearrangement
of the agonist site. LA binding of an agonist to a resting
AChR effectively adds a side-chain-sized structural element
to a region comprised of flexible loops. We speculate that
the LA / HA switch increases PO not by initiating site-
gate energy transfer, but rather by simply stabilizing the
ligand at the agonist site. Side chains in other regions of
the protein appear to change the relative stability of O
mainly by establishing new, local interactions as a conse-
quence of the global isomerization (31). Catch-and-hold
involve rearrangements of the backbone in loop B, loop C,
and the non-a surface. The slightly higher k-values for
aG147 and aW149 compared to aY190 and aY198 suggest
that the loop-B backbone may make a greater contribution
in catch and loop C, in hold.
Receptor activation has traditionally been separated into
two distinct processes, binding and gating. The correlation
in LA and HA binding energies in AChRs requires that
this absolute distinction be reconsidered. The observation
that a binding conformational change that forms the LA
complex is correlated energetically with a gating conforma-
tional change that forms the HA complex indicates that the
two steps of Eq. 1 are not independent. It appears that all of
the intermediate states that link the diffusion of agonists into
the binding pocket and the diffusion of ions across the mem-
brane are stages of a single, integrated process.
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